Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_assertion type Assertion NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_head.
- NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_assertion description "[TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_provenance.
- NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_assertion evidence source_evidence_literature NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_provenance.
- NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_assertion SIO_000772 11840265 NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_provenance.
- NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_assertion wasDerivedFrom befree-20140225 NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_provenance.
- NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_assertion wasGeneratedBy ECO_0000203 NP220526.RAPwiI6ZBkla_M3IwV2n5CmnsONHjvnVF_z-sIaE91R3g130_provenance.